Yu et al. discovered that the four core genes CHIT1, GTSF1L, PLA2G2D, and GNG8 constitute the final features, suggesting that immune scoring depending on these four immune-related genes can serve as an auxiliary standard to effectively predict survival outcomes, tumor infiltration, and immunotherapy efficacy of cervical cancer [27]. This evidence concerns the gene PLA2G2D and cervical carcinoma.